• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

COVID-19 treatment in 2020: a slideshow

Feature
Article

AHRQ publishes estimates for civilian population, not including residents of nursing homes or other institutions.

March 2020 will be remembered for the spread of the COVID-19 pandemic. For the remaining months of 2020, how many people were affected? What types of treatments did they seek?

The U.S. Agency for Healthcare Research and Quality (AHRQ) published estimates in “Healthcare Use and Expenditures for COVID-19, U.S. Civilian Noninstitutionalized Population, 2020,” the agency’s Statistical Brief #549. The findings are based on the Medical Expenditure Panel Survey, which compiles data reported by household respondents.

The figures do not include people in nursing homes or other institutions, or active-duty military service members. Researchers Emily Mitchell, PhD, Rebecca Ahrnsbrak, MPS, and Zhengyi Fang, MS, noted the estimates represent treated prevalence, or people who had COVID-19 and a medical event related to COVID-19. That is a subset of true prevalence, or the total number of people who had COVID-19, regardless of whether they received medical care for the disease.

Related Videos
© National Institute for Occupational Safety and Health